Skip to main content
Retour
Watch Compare

INVO Fertility, Inc.

Qualité des données : 100%
IVF
Nasdaq Manufacturing Measuring & Analyzing Instruments
2,01 €
0,00 € (0,00%)
Cap. Boursière: 13,92 M
Prix
2,00 €
Cap. Boursière
13,92 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 58,41% annually over 5 years — strong growth
Debt/Equity of 0,34 — conservative balance sheet
Negative free cash flow of -7,77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 57,84%
Capital efficient — spends only 1,59% of revenue on capex

Croissance

Revenue Growth (5Y)
58,41%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)116,25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-682,92%
En dessous de la moyenne du secteur (-53,34%)
ROIC-94,17%
Net Margin-417,01%
Op. Margin-141,14%

Sécurité

Debt / Equity
0,34
Au-dessus de la moyenne du secteur (0,31)
Current Ratio0,12
Interest Coverage-10,81

Valorisation

PE (TTM)
-0,48
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio2,38
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B 2,4 1,6
ROE % -682,9 -53,3
Net Margin % -417,0 -41,5
Rev Growth 5Y % 58,4 1,8
D/E 0,3 0,3

Objectif de Cours des Analystes

1 analyste
Strong Buy
Actuel
2,01 €
+895.0%
Objectif
20,00 €
20,00 €
20,00 €
20,00 €
Prévisions
P/E Prévisionnel -0,09
BPA Prévisionnel -23,20 €
CA Est. 10,42 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 -23,20 €
-23,20 € – -23,20 €
 10,42 M 1

Surprises de Résultats

Dernier 1 trimestre
Trimestre BPA Est. BPA Réel Surprise
Q42024 -420,00 € -1 084,80 € -158,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 116,25% Revenue Growth (3Y) 181,86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 58,41% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6,94 M Net Income (TTM) -28,96 M
ROE -682,92% ROA -151,80%
Gross Margin N/A Operating Margin -141,14%
Net Margin -417,01% Free Cash Flow (TTM) -7,77 M
ROIC -94,17% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,34 Current Ratio 0,12
Interest Coverage -10,81 Asset Turnover 0,36
Working Capital -8,11 M Tangible Book Value -1,46 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,48 Forward P/E N/A
P/B Ratio 2,38 P/S Ratio 2,00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55,79%
Market Cap 13,92 M Enterprise Value 15,90 M
Per Share
EPS (Diluted TTM) -46,38 Revenue / Share 1,00
FCF / Share -1,12 OCF / Share -1,10
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,59% FCF Conversion 26,82%
SBC-Adj. FCF N/A Growth Momentum 57,84

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 6,53 M 3,02 M 822 196,0 4,16 M 1,04 M
Net Income -9,10 M -8,03 M -10,89 M -6,65 M -8,35 M
EPS (Diluted) -30,19 -5,13 -0,90 -0,63 -1,52
Gross Profit — — 490 673,0 4,02 M 948 526,0
Operating Income -8,13 M -6,77 M -10,63 M -5,22 M -5,51 M
EBITDA — — — — —
R&D Expenses 489 660,0 165 945,0 544 043,0 216 430,0 398 426,0
SG&A Expenses 9,08 M 7,49 M 10,57 M 9,02 M 6,07 M
D&A 919 603,0 200 894,0 77 301,0 27 760,0 11 917,0
Interest Expense 1,06 M 925 909,0 59 445,0 1,27 M 2,84 M
Income Tax -22 913,0 27 786,0 2 872,0 4 764,0 36,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 46,45 M 20,89 M 4,10 M 10,47 M 10,95 M
Total Liabilities 26,24 M 19,99 M 5,08 M 3,16 M 5,20 M
Shareholders' Equity 12,75 M 892 825,0 -977 612,0 7,31 M 5,74 M
Total Debt — — — — —
Cash & Equivalents — — — 5,68 M 10,10 M
Current Assets 1,32 M 1,26 M 621 087,0 6,31 M 10,54 M
Current Liabilities 17,93 M 8,22 M 3,41 M 1,25 M 2,29 M